COMMUNIQUÉS West-GlobeNewswire

Rose Hill Life Sciences Executes Exclusive License Agreement with Johns Hopkins University for Restoration of Motor Function Post-Neurological Injury Using Psychedelics
03/06/2025
BOSTON, June 03, 2025 (GLOBE NEWSWIRE) -- Rose Hill Life Sciences , a global leader in the research and intellectual property of premium psilocybin products, has signed an agreement with Johns Hopkins University to [...]
QHSLab, Inc. Publishes Peer-Reviewed Studies Validating Digital Tools for Enhancing Patient Outcomes and Healthcare Efficiency
03/06/2025
Recent publications highlight the efficacy of QHSLab's digital assessments in primary care, offering benefits for providers, patients, and practice revenue. WEST PALM BEACH, FL, June 03, 2025 (GLOBE NEWSWIRE) -- QHSLab [...]
Safety Shot, Inc. Developing Next-Generation Nootropic and Sleep Solutions by leveraging Core 'Feel Better Fast' Expertise
03/06/2025
Company to Expand Patented Wellness Approach into High-Growth Cognitive and Restorative Sleep Markets, Emphasizing Scientific Rigor and Unique Formulations SCOTTSDALE, AZ, June 03, 2025 (GLOBE NEWSWIRE) -- Safety Shot, [...]
Nanox to Participate in Sidoti Small Cap Conference
03/06/2025
Management to present on Wednesday, June 11 at 1:45 PM ET PETACH TIKVA, Israel, June 03, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) (“ Nanox ” or the “ Company ”), an innovative medical imaging [...]
NeuroOne Strengthens Leadership Team with Appointment of Emily Johns as General Counsel and Corporate Secretary
03/06/2025
EDEN PRAIRIE, Minn., June 03, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and [...]
Titan Pharmaceuticals Announces Filing of Registration Statement for Proposed Business Combination with TalenTec Sdn. Bhd.
03/06/2025
NEW YORK, June 03, 2025 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (“Titan” or the “Company”) announced today the filing by Black Titan Corporation with the U.S. Securities and Exchange Commission (“ [...]
Babesiosis Incidence in U.S. 10x Higher Than CDC Estimates, According to Insurance Claims Study Commissioned by 60 Degrees Pharmaceuticals
03/06/2025
25,000 U.S. adults per year claim reimbursement for medical costs associated with babesiosis v. CDC estimates of 2,000 A full 45 percent of persistent babesiosis cases include chronic fatigue Healthcare providers [...]
L’AVENIR DE LA PRODUCTION ALIMENTAIRE EST FAIT AU CANADA : Le Défi Cultiver l’innovation d’ici offre une subvention de 20 M$ dans le cadre de sa phase de mise à l’échelle pour soutenir la production alimentaire nationale
03/06/2025
TORONTO, 03 juin 2025 (GLOBE NEWSWIRE) -- Il est plus essentiel que jamais d’assurer au Canada un approvisionnement alimentaire sécuritaire et durable. Poursuivant son engagement de longue date envers l’amélioration du [...]
THE FUTURE OF FOOD IS MADE IN CANADA: The Homegrown Innovation Challenge Launches $20M Scaling Phase Grant to Support Domestic Food Production
03/06/2025
TORONTO, June 03, 2025 (GLOBE NEWSWIRE) -- It has never been more important for Canada to have a secure and sustainable supply of food. Building on its longstanding commitment to improving the well-being of Canadians, [...]
BON Announces Share Repurchase Program for up to US$1.0 Million
03/06/2025
XI’AN, China, June 03, 2025 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) (“BON” or the “Company”), a leading bio-ingredient solution provider in the natural, health and personal care industry, today [...]
Foundational US Patent Granted for ECG Assessment of Heart Function, Further Expands HeartSciences’ Patent Portfolio and IP Value
03/06/2025
Patent covers estimation of measures of heart function using an ECG, which are critical in the diagnosis and early detection of heart disease Southlake, TX, June 03, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: [...]
H1 Acquires Veda to Solve Healthcare’s Provider Data Challenge and Power Better Care
03/06/2025
Acquisition equips health plans with next-generation provider data management, enabling improved access to care and better health outcomes NEW YORK, June 03, 2025 (GLOBE NEWSWIRE) -- H1 , on a mission to connect the [...]
BioAge Expands APJ Agonist Pipeline with Oral Small-Molecule and Long-Acting Biologic Candidates
03/06/2025
Company enters option agreement with JiKang Therapeutics to in-license novel APJ agonist antibody New composition of matter IP filed for chemically distinct, orally active, and highly potent small molecule APJ agonists [...]
Myriad Genetics Announces Early Access to the FirstGene Multiple Prenatal Screen
03/06/2025
Screening test provides prenatal risk assessment for common genetic conditions in one blood draw without the need for paternal testing Early access via large-scale clinical study to establish the validity and utility of [...]
Connect Biopharma Announces Two Oral Presentations at the European Academy of Allergy and Clinical Immunology (EAACI) 2025 Annual Congress
03/06/2025
SAN DIEGO, June 03, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma” or the “Company”), a clinical-stage biopharmaceutical company focused on transforming acute and chronic [...]
Visory Health Survey Reveals Critical Gap in Prescription Savings for Uninsured Spanish Speakers
03/06/2025
Nearly half of uninsured Spanish speakers are unfamiliar with prescription discount cards – a gap that’s putting affordable medications out of reach for millions ESTERO, Fla., June 03, 2025 (GLOBE NEWSWIRE) -- Visory [...]
CancerVax Scientists Featured on Cytiva’s “Discovery Matters” Podcast Discussing Universal Cancer Vaccine Platform
03/06/2025
Dr. George Katibah and Dr. Adam Grant describe the features and progress of the Company’s revolutionary technology Lehi, June 03, 2025 (GLOBE NEWSWIRE) -- Lehi, Utah – June 3rd, 2025 – CancerVax, Inc., the developer of [...]
Kamari Pharma Announces Closing of $23 Million Financing to Advance its First-In-Class Oral TRPV3 Inhibitor for Rare Genetic Skin Diseases
03/06/2025
Financing co-led by new investor BRM Group and existing investor Pontifax Lead program KM023 is a first-in-class oral TRPV3 inhibitor entering clinical development for the treatment of three rare genetic skin diseases; [...]
Oculis to Participate in Upcoming June Investor Conferences
03/06/2025
ZUG, Switzerland, June 03, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / ICX: OCS.IC) (“Oculis”), a global biopharmaceutical company focused on innovations addressing ophthalmic and neuro-ophthalmic diseases [...]

Pages